Oryzon Genomics Balance Sheet Health
Financial Health criteria checks 4/6
Oryzon Genomics has a total shareholder equity of $85.7M and total debt of $21.3M, which brings its debt-to-equity ratio to 24.8%. Its total assets and total liabilities are $114.2M and $28.5M respectively.
Key information
24.8%
Debt to equity ratio
US$21.29m
Debt
| Interest coverage ratio | n/a |
| Cash | US$14.65m |
| Equity | US$85.70m |
| Total liabilities | US$28.48m |
| Total assets | US$114.18m |
Recent financial health updates
Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04
Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26Recent updates
Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch
Jun 09Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts
Jul 24Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns
Jan 04
Financial Position Analysis
Short Term Liabilities: ORY's short term assets ($20.3M) exceed its short term liabilities ($16.8M).
Long Term Liabilities: ORY's short term assets ($20.3M) exceed its long term liabilities ($11.7M).
Debt to Equity History and Analysis
Debt Level: ORY's net debt to equity ratio (7.7%) is considered satisfactory.
Reducing Debt: ORY's debt to equity ratio has reduced from 58% to 24.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ORY has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ORY has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.